Diversified Energy Company plc
SC 13G – Schedule filed to report acquisition of beneficial ownership[...]
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor)[...]
Transporeon's Latest Report Reveals Shipper and Carrier Perspectives on[...]
12/06/2022 | Press release | Distributed by Public on 12/06/2022 07:26
Please select the service you want to use:
Smartlinks | Achilles Therapeutics plc | News | Health | Company News | Top Company News | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Düsseldorf | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact